Insight, innovation, and intelligence took center stage at the 2018 Pharma CI Conference & Exhibition, the best and largest assembly of competitive intelligence executives in pharma, biotech, and medical devices in the world for 10 years. It was recently held at the Newark Liberty International Marriott Hotel in Newark, New Jersey (and returns to this same venue on September 18-19, 2019).
Conference attendees experienced keynote presentations, peer-to-peer sessions, and track sessions focusing on topics including developing a competitive edge, artificial intelligence, critical techniques, collaboration, and industry challenges, among others. They also gained exclusive access to the exhibition floor and networked with celebrated CI influencers.
The talks included senior-level thought leaders from prestigious companies, including Abbott, AbbVie, Amicus Therapeutics, AstraZeneca, Atara Biotherapeutics, Bayer Consumer Health, BioMarin, Boehringer Ingelheim, Celgene, Click Therapeutics, Comcast, Daiichi Sankyo, Eagle Pharmaceuticals, Eli Lilly, Intercept Pharmaceuticals, Ipsen, Ironwood Pharmaceuticals, Junto Health, Medtronic, Merck & Co., Novartis, NS3 Biotech, Patheon, Pear Therapeutics, Pfizer, REGENXBIO, Roche, Sanofi Pasteur, Taiho Oncology, Takeda Pharmaceuticals, TESARO, United Therapeutics, West Pharmaceutical Services, and more.
Buzz is already building for the 2019 Pharma CI Conference. Meanwhile, its popular companion event, the Pharma Market Research Conference (PMRC) celebrates its 10th year on February 6-7, 2019 at the Newark Liberty International Airport Marriott. Then, go international for the 8th Annual Pharma CI Europe Conference March 5-6, 2019 in Basel, Switzerland. For additional information, visit http://www.pharmaciconference.com.
